E. Epoch Biosciences / J. Only Epoch Biosciences / P. ViraCor Laboratories / Quality Assurance ViraCor Laboratories / I. Epoch Biosciences / N. ARUP Laboratories / Qiagen / F. Epoch Biosciences / Notices 35053 M. ARUP Laboratories / Epoch Biosciences A. Epoch Biosciences / Ambion Inc. / Epoch BioSciences / C. ViraCor Laboratories / Q. Epoch Biosciences / O. ViraCor Laboratories / A. ViraCor Laboratories Inc. / I. ViraCor Laboratories / ABI Software / Notices 35051 The ELITech Molecular Diagnostics / CLIA High Complexity Laboratories / The ELITech Molecular Diagnostics / N. Only ViraCor Laboratories / Wescor Inc. / E. ViraCor Laboratories / ARUP Laboratories / H. Epoch Biosciences / D. Epoch Biosciences / C. Epoch Biosciences / M. ViraCor Laboratories / L. ARUP Laboratories / IQuum Inc. / L. ViraCor Laboratories / Authorized ELITech Molecular Diagnostics / Notices 35049 D. ViraCor Laboratories / ViraCor Laboratories / NOTICES ARUP Laboratories K. ARUP Laboratories / Diagnostic Hybrids Inc. / ARUP Laboratories P. Epoch Biosciences / B. ViraCor Laboratories / O. ARUP Laboratories / B. Epoch Biosciences / J. ViraCor Laboratories / M.D. / NOTICES ARUP Laboratories / /
Country
United States / /
Event
Natural Disaster / FDA Phase / /
Facility
University Pathologists / /
IndustryTerm
software version / manufacturing practice requirements / patient specimen processing / investigational devices / unapproved medical product / healthcare providers / detection systems / biological product / federal law / /
MedicalCondition
specified disease / seasonal influenza A / such a disease / H1N1 influenza virus / Influenza A / diseases / respiratory infection / swine origin influenza A / such disease / Swine Influenza A / H1N1 influenza virus infection / influenza / H1N1 Influenza A / H1N1 influenza / disease / H1N1 flu / involving Swine Influenza A / /
Organization
U.S. Department of Health and Human Services / Bethesda Metro Center / Center for Disease Control / Division of Wescor / office of New Animal Drug Evaluation / Center for Veterinary Medicine / CLIA High Complexity Laboratory / Food and Drug Administration / Availability AGENCY / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / National Park Service / office of Counterterrorism and Emerging Threats / /
Person
Longhorn Vaccines / Walt Mahoney / Boris Lushniak / Elizabeth Rettie / Silver Spring / Charles E. Johnson / Gerald W. Fischer / Margaret A. Hamburg / /
Position
H1N1 Real-Time RT / Secretary / Executive Director and Chief Medical Officer / VP R&D and Operations Managing Director Epoch BioSciences / Secretary of Defense / LC RT / ASQ CQA Director / Regulatory Affairs / Real-time RT / Governor / Acting Secretary / Deputy Director / Commissioner / virus Real-Time RT / /
Product
BAL / Authorization / Longhorn Influenza / DSKD5P82C1PROD / /
ProvinceOrState
Washington / Missouri / Maryland / /
PublishedMedium
Public Law / /
Technology
in vitro diagnostics / hybridization / 1001 NW Technology / process control / /
Federal Register / Vol. 75, No[removed]Monday, June 21, [removed]Notices Dated: June 15, 2010. Elizabeth Rettie, Deputy Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 2010–14865 F